TScan Therapeutics Announces Exercise of Underwriters'
WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Source: globenewswire.com
📰 Sci Capital News
Sci Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sci Capital. Real-time updates on events, politics, business and more.
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
Boca Raton, Florida - INmune Bio, Inc. , a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced today...
Source: marketscreener.com
TScan Therapeutics Announces Closing of Upsized Public Offering
WALTHAM, Mass., April 19, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...
Source: marketscreener.com
TScan Therapeutics Announces Closing of Upsized Public
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Source: globenewswire.com
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares -February 16, 2024 at 04:22 pm EST
BALA CYNWYD, Pa., Feb. 16, 2024 -- Larimar Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of...
New York United States Michael Celano Joyce Allaire Broadridge Financial Solutions Equity Syndicate Department
Source: marketscreener.com
Vera Therapeutics Announces Pricing of Upsized Public
BRISBANE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and...
Source: globenewswire.com
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...
Source: marketscreener.com
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares -January 30, 2024 at 07:02 am EST
CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder...
New York United States Exchange Commission Goldman Sachs Co Prospectus Department Cantor Fitzgerald Co
Source: marketscreener.com
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the pricing of an underwritten offering...
New York United States Company Quarterly Report On Form Evercore Group Equity Syndicate Prospectus Department Exchange Commission
Source: marketscreener.com
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...
Source: marketscreener.com